Login

Cohance Lifesciences Ltd.

₹1063.8

Overview Charts Peers Quarters Profit & Loss Balance Sheet Cash Flow Ratios Investors Corp. Action Documents
Consolidated
Standalone

Cohance Lifesciences Ltd.

₹1063.8

₹1063.8

7.15 (0.68%) - 16 Jul 2025 04:28 PM

About Company

Suven Pharmaceuticals Limited is a bio-pharmaceutical company, incorporated with the object of being engaged in the business of development and manufacturing of New Chemical Entity (NCE) based Intermediates, Active Pharmaceutical Ingredients (API), Speciality Chemicals and formulated drugs under contract research and manufacturing services for global pharmaceutical, biotechnology and chemical companies. Suven Pharma Inc., a Delaware Company, is a WOS (wholly owned subsidiary) of SPL, is a SPV (Special Purpose Vehicle) created on 9th March 2019, for undertaking various business opportunities in Pharma Industry.

Market Cap. ₹ 40,424 Cr.
52 Week - High/Low ₹ 1,360/815
P/E Ratio 98.84
P/B Ratio 19.66
Enterprise Value ₹ 40,463 Cr.
ROE % 16.03
RSI Value 63.91
EMA 50 996.01
EMA 200 993.91
Market Cap. ₹ 40,424 Cr.
52 Week - High/Low ₹ 1,360/815
P/E Ratio 100.35
P/B Ratio 19.71
Enterprise Value ₹ 41,164 Cr.
ROE % 15.87
RSI Value 63.91
EMA 50 996.01
EMA 200 993.91
Add Parameters

Growth

Valuation

Calculators

Peer Comparison

Industry - Pharmaceuticals & Drugs

* Please refer to the Standalone data if Consolidated financial data for the company is not available.

Shareholding Pattern Numbers in percentages

Insight market
Terms | Privacy | Contact Us
Copyright © 2025 All rights reserved with INVESMATE INSIGHTS PRIVATE LIMITED | All logos and Trademarks registered with their respective owners.